Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03615781Completed
Randomised, open-label trial in septic arthritis (2 arms). Primary endpoints: Clinical Remission of systemic infection at 6 months and Sequels at 6 months. Started Jun 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03615781.